Zuo Fanjiao, Zhu Yameng, Wu Tiantian, Li Caixia, Liu Yang, Wu Xiwei, Ma Jinyue, Zhang Kaili, Ouyang Huizi, Qiu Xilong, He Jun
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Pharmaceutics. 2024 Sep 16;16(9):1214. doi: 10.3390/pharmaceutics16091214.
Recent developments in nanotechnology have provided efficient and promising methods for the treatment of diseases to achieve better therapeutic results and lower side effects. Titanium dioxide (TiO) nanomaterials are emerging inorganic nanomaterials with excellent properties such as low toxicity and easy functionalization. TiO with special nanostructures can be used as delivery vehicles for drugs, genes and antigens for various therapeutic options. The exploration of TiO-based drug delivery systems shows great promise for translating nanotechnology into clinical applications; Comprehensive data on titanium dioxide were collected from reputable online databases including PubMed, GreenMedical, Web of Science, Google Scholar, China National Knowledge Infrastructure Database, and National Intellectual Property Administration; In this review, we discuss the synthesis pathways and functionalization strategies of TiO. Recent advances of TiO as a drug delivery system, including sustained and controlled drug release delivery systems were introduced. Rigorous long-term systematic toxicity assessment is an extremely critical step in application to the clinic, and toxicity is still a problem that needs to be closely monitored; Despite the great progress made in TiO-based smart systems, there is still a great potential for development. Future research may focus on developing dual-reaction delivery systems and single-reaction delivery systems like redox and enzyme reactions. Undertaking thorough in vivo investigations is necessary prior to initiating human clinical trials. The high versatility of these smart drug delivery systems will drive the development of novel nanomedicines for personalized treatment and diagnosis of many diseases with poor prognosis.
纳米技术的最新进展为疾病治疗提供了高效且有前景的方法,以实现更好的治疗效果并降低副作用。二氧化钛(TiO)纳米材料是新兴的无机纳米材料,具有低毒性和易于功能化等优异特性。具有特殊纳米结构的TiO可作为药物、基因和抗原的递送载体,用于各种治疗选择。基于TiO的药物递送系统的探索对于将纳米技术转化为临床应用显示出巨大的前景;从包括PubMed、绿色医学、科学网、谷歌学术、中国知网数据库和国家知识产权局在内的知名在线数据库收集了关于二氧化钛的综合数据;在本综述中,我们讨论了TiO的合成途径和功能化策略。介绍了TiO作为药物递送系统的最新进展,包括持续和控释药物递送系统。严格的长期系统毒性评估是应用于临床的极其关键的一步,毒性仍然是需要密切监测的问题;尽管基于TiO的智能系统取得了巨大进展,但仍有很大的发展潜力。未来的研究可能集中在开发双反应递送系统和单反应递送系统,如氧化还原和酶反应。在启动人体临床试验之前,进行彻底的体内研究是必要的。这些智能药物递送系统的高度通用性将推动新型纳米药物的开发,用于个性化治疗和诊断许多预后不良的疾病。